Please login to the form below

Not currently logged in
Email:
Password:

New EU rules on falsified medicines

The European Union has published a new directive to prevent falsified or counterfeit medicines entering the legal supply chain

The European Union has published a new Directive (pdf) to prevent falsified or counterfeit medicines entering the legal supply chain.

Published in the Official Journal of the European Union, the directive outlines regulation to increase safety and strengthen control measures across the continent.

Methods include obligatory features on the outer packaging of medicines to demonstrate authenticity; strengthened requirements for the inspection of the manufacturers of pharmaceutical ingredients; and enforcing an obligation for manufacturers and distributors to report any suspicion of falsified medicines.

A logo that must also be placed on the websites of legally operating online pharmacies, with a link to official national registers.

The European Medicines Agency (EMA) said it welcomed the rules, and that the agency would be working closely with the European Commission over the next 18 months to implement the legislation.

The Directive is scheduled to come into force on July 21, 2011, with the application of its measures necessary from all Member States by January, 2013.

5th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics